Hormone Replacement Therapy

hormone replacement therapy () places women at a greater risk for , blood clots, heart attack and stroke

() is medication containing one or more female hormones, commonly estrogen plus progestin. is often prescribed to treat symptoms of menopause such as “hot flashes,” vaginal dryness, mood swings, sleep disorders, and decreased sexual desire. This medication may be taken in the form of a pill, a patch, or vaginal cream.

Until recently, doctors believed the long-term use of drugs such as Premarin, Provera, and Prempro were safe and protected against osteoporosis and heart disease.

However, recent studies now show that places women at a higher risk for:

  • ovarian cancer
  • non-hodgkins lymphoma
  • heart attack
  • stroke
  • blood clots

For more information, read the specific criteria for qualified HRT injuries.

have you been seriously injured while on ?

If you or a loved one has suffered serious side effects while taking drugs such as Premarin, Provera, and Prempro, if you have been diagnosed with , or if you experiencing symptoms associated with , you may have a claim against the manufacturer.

Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.

Latest News

Study: HRT puts women at greater risk for lung cancer

HRT woman with patchThe reports of health problems associated with hormone replacement therapy () keep coming. First, the Women’s Health Initiative identified women who took the combined estrogen-plus-progestin therapy were at a much greater risk of developing . It later showed these women were at an increased risk of heart disease and other serious health problems. Now, an article published online in the Journal of Clinical Oncology suggests that women who took combined are at an increased risk of lung cancer by as much as 50 percent.

Read the rest of this entry »

Ghostwritten medical journal articles about HRT should be retracted

JournalofWomensHealth 100x100William T. Creasman was listed as the author of an article written by a freelance writer for the December 1998 Journal of Women’s Health. The title: “Is there an association between hormone replacement therapy and ?” The article points out that there is no “definitive evidence” that is linked to . But the dirty little secret behind that article in the medical journal is that Creasman didn’t actually write the article. It was authored by a writer for DesignWrite, a marketing firm that represented -maker Wyeth, now owned by Pfizer. As the story was going to press, Wyeth was covering up evidence that proved otherwise. The drug company’s estrogen-plus-progestin was, in fact, increasing a woman’s risk for as well as heart disease and Alzheimer’s.

Read the rest of this entry »

Estrogen-only HRT linked to asthma after menopause

asthma 100x100A study involving nearly 58,000 women in France over a 12-year period suggests that hormone replacement therapy () may increase a woman’s risk of developing asthma after menopause. Researchers from the Gustave Roussy Institute in France and the Instituto Nacional de Salud Publica in Mexico published the findings in the British medical journal, Thorax. The study suggested that women who took were 21 percent more likely to develop asthma than women who did not take . The risk was even greater for women who took estrogen-only compared to the combined estrogen-plus-progestin therapy, with the estrogen-only group at 54 percent greater risk of developing asthma compared to women who did not take . This is the first long-term, large-scale study to suggest that estrogen-only puts women at much greater risk of asthma than the combined therapy.

Read the rest of this entry »